3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
2
Withdrawn
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
11
Adenocarcinoma of Lung
4
Rectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Neoplastic Cells, Circulating
1
Lymphedema
1
Lung Neoplasms
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Interventions
Tamoxifen
6
Specimen Handling
6
Anastrozole
3
exemestane
2
Surveys and Questionnaires
2
Radiosurgery
2
Letrozole
2
Genetic Testing
2
Biopsy
2
poly ICLC
1
elacestrant
1
Testosterone
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
Selective Estrogen Receptor Modulators
1
Restraint, Physical
1
Radiotherapy
1
Practice Guidelines as Topic
1
Patient Navigation
1
Omacor
1
Multicenter Studies as Topic
1
Methods
1
Meditation
1
Medicare
1
Mastectomy, Segmental
1
Mastectomy
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Follow-Up Studies
1
FAPI-46
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Intraductal, Noninfiltrating
×
Mastectomy, Segmental
×
Clear all
NCT03909282
2026-03-12
NORDIS
Stanford University
Phase NA
Recruiting
50 enrolled